Sarasota Memorial Hospital is using an innovative heat-free waterjet – powered by robotics and artificial intelligence – to ...

Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...

UCHealth hospital uses BPH AI to guide aquablation, improving precision and preserving sexual function in prostate treatment.

The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...

TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLift™ System with Rezūm™ ...

GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).

GOLDEN VALLEY, Minn. — Earlier this year, King Charles underwent a procedure for an enlarged prostate, which sparked interest in the extremely common condition among older men. Rowe Winecoff of Edina ...

Drug therapy for BPH can be categorized into two groups: agents that interfere with testosterone's stimulatory effect on prostate enlargement and agents that relax prostatic smooth muscle. Of the ...

DUBLIN, Aug. 25, 2025 /PRNewswire/ -- ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the ...

Ever woken up multiple times at night, groggy and frustrated, just to rush to the bathroom? You might blame your bladder, or ...